Text Size
967 studies found for:    "Etoposide phosphate"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Withdrawn Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung Cancer
Condition: Extensive-stage Small Cell Lung Cancer
Interventions: Drug: Obatoclax Mesylate, Carboplatine and Etoposide;   Drug: Carboplatin and Etoposide
2 Completed Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
Conditions: Gliosarcoma;   Glioblastoma
Intervention: Drug: Vandetanib and Etoposide
3 Completed
Has Results 		Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
Conditions: Glioblastoma;   Gliosarcoma
Interventions: Drug: Temo + Avastin;   Drug: VP-16 + Avastin
4 Suspended A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
Conditions: Lymphoblastic Leukemia, Acute, Childhood;   Lymphoblastic Lymphoma;   Peripheral T-cell Lymphoma
Interventions: Drug: Temsirolimus;   Drug: Dexamethasone;   Drug: Etoposide;   Drug: Etoposide phosphate;   Drug: Cyclophosphamide;   Drug: Methotrexate;   Drug: Hydrocortisone;   Drug: Cytarabine
5 Completed
Has Results 		Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Condition: Extensive Stage Small Cell Lung Cancer
Interventions: Biological: G-CSF;   Drug: Cisplatin;   Drug: Etoposide;   Drug: Irinotecan;   Drug: Topotecan
6 Active, not recruiting
Has Results 		Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: IV Cisplatin and Oral Protracted Etoposide for induction;   Drug: Adriamycin and Cyclophosphamide;   Drug: IV Cisplatin and IV Bolus Etoposide
7 Active, not recruiting Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer
Interventions: Biological: cixutumumab;   Drug: vismodegib;   Drug: cisplatin;   Drug: etoposide phosphate
8 Unknown † Ph II Bevacizumab + Etoposide for Pts w Recurrent MG
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Bevacizumab and Etoposide
9 Terminated Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Intervention: Drug: LBH589 and carboplatin with etoposide
10 Active, not recruiting Further Retrospect Clinical Study for FDA IND Exemption - Etoposide and Single Nucleotide Polymorphisms
Condition: Small Cell Lung Cancer
Interventions: Drug: ETOPOSIDE INJECTION;   Drug: CISPLATIN INJECTION
11 Active, not recruiting Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children
Conditions: Recurrent Brain Tumors;   Supratentorial PNETs;   Medulloblastomas;   Ependymomas
Interventions: Drug: carboplatin;   Drug: etoposide;   Drug: temozolomide;   Drug: thiotepa, carboplatin, etoposide;   Drug: temozolomide, thiotepa;   Procedure: autologous stem cell transplantation;   Drug: trofosfamide/etoposide
12 Recruiting Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone
Condition: Small Cell Lung Carcinoma
Interventions: Biological: Ipilimumab;   Biological: Placebo matching Ipilimumab;   Drug: Etoposide;   Drug: Cisplatin;   Drug: Carboplatin
13 Recruiting Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Etoposide
14 Recruiting Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer
Condition: Small Cell Lung Carcinoma, Extensive Disease
Interventions: Drug: Cisplatin + etoposide;   Drug: Epirubicin + ifosfamide + etoposide
15 Completed A Phase 1b/2 Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer
Conditions: Lung Cancer;   Small Cell Lung Cancer;   Solid Tumors;   Extensive-stage Small Cell Lung Cancer
Interventions: Drug: AMG 479 in combination with Cisplatin/Etoposide;   Drug: AMG 479 in combination with Carboplatin/Etoposide;   Drug: Placebo in combination with Cisplatin/Etoposide;   Drug: AMG 102 in combination with Cisplatin/Etoposide;   Drug: Placebo in combination with Carboplatin/Etoposide;   Drug: AMG 102 in combination with Carboplatin/Etoposide
16 Completed IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML)
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: Plerixafor;   Drug: Mitoxantrone;   Drug: Etoposide;   Drug: Cytarabine
17 Recruiting Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide for Refractory or Relapsed Aggressive B-Cell Lymphomas
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: Bendamustine;   Drug: Ofatumumab;   Drug: Carboplatin;   Drug: Etoposide;   Procedure: CT Scan;   Procedure: PET Scan;   Genetic: Stem Cell Transplant (STC)
18 Not yet recruiting Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia
Interventions: Drug: Clofarabine;   Drug: Etoposide;   Drug: Cyclophosphamide;   Biological: allogeneic hematopoietic cell transplantation
19 Terminated
Has Results 		A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide
Condition: Carcinoma, Small Cell
Interventions: Drug: Pomalidomide;   Drug: Cisplatin;   Drug: Etoposide
20 Completed Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer
Interventions: Biological: oblimersen sodium;   Drug: carboplatin;   Drug: etoposide
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years